08:00 , Feb 16, 2015 |  BC Week In Review  |  Company News

CytoSorbents, Aferetica deal

CytoSorbents granted Aferetica exclusive, Italian distribution rights to CytoSorb cytokine reduction therapy for critical care applications. The extracorporeal cytokine filtration device has CE Mark approval for indications in which cytokines are elevated, including sepsis...